APA (7th ed.) Citation

F, P., F, P., M, P., R, S., F, C., F, P., . . . J, H. (2026). Real-Life Efficacy and Safety of BRAF Inhibitors in Erdheim-Chester Disease. American journal of hematology, 101(1), 182. https://doi.org/10.1002/ajh.70137

Chicago Style (17th ed.) Citation

F, Pegoraro, et al. "Real-Life Efficacy and Safety of BRAF Inhibitors in Erdheim-Chester Disease." American Journal of Hematology 101, no. 1 (2026): 182. https://doi.org/10.1002/ajh.70137.

MLA (9th ed.) Citation

F, Pegoraro, et al. "Real-Life Efficacy and Safety of BRAF Inhibitors in Erdheim-Chester Disease." American Journal of Hematology, vol. 101, no. 1, 2026, p. 182, https://doi.org/10.1002/ajh.70137.